For the active substances Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, cyflumetofen, Helicoverpa armigera nucleopolyhedrovirus, metam, rescalure, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237, the Authority needs additional time to reach a conclusion on the risk. Taking into account the subsequent steps to be completed in each renewal procedure, the duration of the extension of the approval periods of these active substances should be set at 19 and a half months for clodinafop, at 23 and a half months for Beauveria bassiana strains ATCC 74040 and GHA, cyflumetofen, Helicoverpa armigera nucleopolyhedrovirus, metam, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237, and at 29 months for rescalure.
Recital 39, Regulation (EU) 2025/1489
In forcesince 24 Jul 2025